<?xml version="1.0"?>
<rss version="2.0">
 <channel>
  <title>StreetInsider.com News Articles</title>
  <link>http://www.streetinsider.com</link>
  <description>Latest StreetInsider.com News Articles</description>
  <language>en-us</language>
  <copyright>Copyright 2026, StreetInsider.com</copyright>
  <managingEditor>rss@streetinsider.com (SI RSS)</managingEditor>
  <webMaster>rss@streetinsider.com (SI RSS)</webMaster>
  <lastBuildDate>Wed, 13 May 2026 11:57:00 -0400</lastBuildDate>
  <docs>http://blogs.law.harvard.edu/tech/rss</docs>
  <image>
   <url>http://www.streetinsider.com/images/rss_logo.gif</url>
   <title>StreetInsider.com News Articles</title>
   <link>http://www.streetinsider.com</link>
   <width>143</width>
   <height>28</height>
  </image>
  <skipHours>
   <hour>0</hour>
   <hour>1</hour>
   <hour>2</hour>
   <hour>3</hour>
   <hour>21</hour>
   <hour>22</hour>
   <hour>23</hour>
  </skipHours>
  <skipDays>
   <day>Saturday</day>
   <day>Sunday</day>
  </skipDays>
  <item>
   <title>ONWARD Medical Announces Results of the 2026 Annual General Meeting of Shareholders</title>
   <link>http://www.streetinsider.com/Press+Releases/ONWARD+Medical+Announces+Results+of+the+2026+Annual+General+Meeting+of+Shareholders/26484281.html</link>
   <description>
&lt;p align=&quot;center&quot;&gt;THIS PRESS RELEASE CONTAINS INSIDE INFORMATION WITHIN THE MEANING OF ARTICLE 7(1) OF THE EUROPEAN MARKET ABUSE REGULATION (596/2014)&lt;/p&gt;  &lt;p align=&quot;center&quot;&gt;&lt;em&gt;Shareholders approve all proposed resolutions&lt;/em&gt;&lt;/p&gt;  &lt;p align=&quot;justify&quot;&gt;EINDHOVEN, the Netherlands, May  13, 2026  (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: ONWD – US ADR: ONWRY), the leading neurotechnology company pioneering therapies to restore movement, function, and independence in people with spinal cord injuries (SCI) and other movement disabilities, today announced that all proposed resolutions at its Annual General Meeting of Shareholders (AGM) were duly passed.&lt;/p&gt;  &lt;p align=&quot;justify&quot;&gt;The meeting was held today in Amsterdam, the Netherlands.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/ONWARD+Medical+Announces+Results+of+the+2026+Annual+General+Meeting+of+Shareholders/26484281.html</guid>
   <pubDate>Wed, 13 May 2026 11:57:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.26337272</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ONWD</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ONWD</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ONWRY</category>
   	  </item>
  <item>
   <title>ONWARD Medical Announces Results of the 2026 Annual General Meeting of Shareholders</title>
   <link>http://www.streetinsider.com/Press+Releases/ONWARD+Medical+Announces+Results+of+the+2026+Annual+General+Meeting+of+Shareholders/26484281.html</link>
   <description>
&lt;p align=&quot;center&quot;&gt;THIS PRESS RELEASE CONTAINS INSIDE INFORMATION WITHIN THE MEANING OF ARTICLE 7(1) OF THE EUROPEAN MARKET ABUSE REGULATION (596/2014)&lt;/p&gt;  &lt;p align=&quot;center&quot;&gt;&lt;em&gt;Shareholders approve all proposed resolutions&lt;/em&gt;&lt;/p&gt;  &lt;p align=&quot;justify&quot;&gt;EINDHOVEN, the Netherlands, May  13, 2026  (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: ONWD – US ADR: ONWRY), the leading neurotechnology company pioneering therapies to restore movement, function, and independence in people with spinal cord injuries (SCI) and other movement disabilities, today announced that all proposed resolutions at its Annual General Meeting of Shareholders (AGM) were duly passed.&lt;/p&gt;  &lt;p align=&quot;justify&quot;&gt;The meeting was held today in Amsterdam, the Netherlands.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/ONWARD+Medical+Announces+Results+of+the+2026+Annual+General+Meeting+of+Shareholders/26484281.html</guid>
   <pubDate>Wed, 13 May 2026 11:57:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.26337272</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ONWD</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ONWD</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ONWRY</category>
   	  </item>
  <item>
   <title>ONWARD Medical Announces Results of the 2026 Annual General Meeting of Shareholders</title>
   <link>http://www.streetinsider.com/Press+Releases/ONWARD+Medical+Announces+Results+of+the+2026+Annual+General+Meeting+of+Shareholders/26484281.html</link>
   <description>
&lt;p align=&quot;center&quot;&gt;THIS PRESS RELEASE CONTAINS INSIDE INFORMATION WITHIN THE MEANING OF ARTICLE 7(1) OF THE EUROPEAN MARKET ABUSE REGULATION (596/2014)&lt;/p&gt;  &lt;p align=&quot;center&quot;&gt;&lt;em&gt;Shareholders approve all proposed resolutions&lt;/em&gt;&lt;/p&gt;  &lt;p align=&quot;justify&quot;&gt;EINDHOVEN, the Netherlands, May  13, 2026  (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: ONWD – US ADR: ONWRY), the leading neurotechnology company pioneering therapies to restore movement, function, and independence in people with spinal cord injuries (SCI) and other movement disabilities, today announced that all proposed resolutions at its Annual General Meeting of Shareholders (AGM) were duly passed.&lt;/p&gt;  &lt;p align=&quot;justify&quot;&gt;The meeting was held today in Amsterdam, the Netherlands.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/ONWARD+Medical+Announces+Results+of+the+2026+Annual+General+Meeting+of+Shareholders/26484281.html</guid>
   <pubDate>Wed, 13 May 2026 11:57:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.26337272</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ONWD</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ONWD</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ONWRY</category>
   	  </item>
  <item>
   <title>ONWARD Medical Announces Results of the 2026 Annual General Meeting of Shareholders</title>
   <link>http://www.streetinsider.com/Press+Releases/ONWARD+Medical+Announces+Results+of+the+2026+Annual+General+Meeting+of+Shareholders/26484281.html</link>
   <description>
&lt;p align=&quot;center&quot;&gt;THIS PRESS RELEASE CONTAINS INSIDE INFORMATION WITHIN THE MEANING OF ARTICLE 7(1) OF THE EUROPEAN MARKET ABUSE REGULATION (596/2014)&lt;/p&gt;  &lt;p align=&quot;center&quot;&gt;&lt;em&gt;Shareholders approve all proposed resolutions&lt;/em&gt;&lt;/p&gt;  &lt;p align=&quot;justify&quot;&gt;EINDHOVEN, the Netherlands, May  13, 2026  (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: ONWD – US ADR: ONWRY), the leading neurotechnology company pioneering therapies to restore movement, function, and independence in people with spinal cord injuries (SCI) and other movement disabilities, today announced that all proposed resolutions at its Annual General Meeting of Shareholders (AGM) were duly passed.&lt;/p&gt;  &lt;p align=&quot;justify&quot;&gt;The meeting was held today in Amsterdam, the Netherlands.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/ONWARD+Medical+Announces+Results+of+the+2026+Annual+General+Meeting+of+Shareholders/26484281.html</guid>
   <pubDate>Wed, 13 May 2026 11:57:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.26337272</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ONWD</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ONWD</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ONWRY</category>
   	  </item>
  <item>
   <title>ONWARD Medical Announces Results of the 2026 Annual General Meeting of Shareholders</title>
   <link>http://www.streetinsider.com/Globe+Newswire/ONWARD+Medical+Announces+Results+of+the+2026+Annual+General+Meeting+of+Shareholders/26484281.html</link>
   <description>
&lt;p align=&quot;center&quot;&gt;THIS PRESS RELEASE CONTAINS INSIDE INFORMATION WITHIN THE MEANING OF ARTICLE 7(1) OF THE EUROPEAN MARKET ABUSE REGULATION (596/2014)&lt;/p&gt;  &lt;p align=&quot;center&quot;&gt;&lt;em&gt;Shareholders approve all proposed resolutions&lt;/em&gt;&lt;/p&gt;  &lt;p align=&quot;justify&quot;&gt;EINDHOVEN, the Netherlands, May  13, 2026  (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: ONWD – US ADR: ONWRY), the leading neurotechnology company pioneering therapies to restore movement, function, and independence in people with spinal cord injuries (SCI) and other movement disabilities, today announced that all proposed resolutions at its Annual General Meeting of Shareholders (AGM) were duly passed.&lt;/p&gt;  &lt;p align=&quot;justify&quot;&gt;The meeting was held today in Amsterdam, the Netherlands.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/ONWARD+Medical+Announces+Results+of+the+2026+Annual+General+Meeting+of+Shareholders/26484281.html</guid>
   <pubDate>Wed, 13 May 2026 11:57:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.26337272</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ONWD</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ONWD</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ONWRY</category>
   	  </item>
  <item>
   <title>ONWARD Medical Announces Results of the 2026 Annual General Meeting of Shareholders</title>
   <link>http://www.streetinsider.com/Globe+Newswire/ONWARD+Medical+Announces+Results+of+the+2026+Annual+General+Meeting+of+Shareholders/26484281.html</link>
   <description>
&lt;p align=&quot;center&quot;&gt;THIS PRESS RELEASE CONTAINS INSIDE INFORMATION WITHIN THE MEANING OF ARTICLE 7(1) OF THE EUROPEAN MARKET ABUSE REGULATION (596/2014)&lt;/p&gt;  &lt;p align=&quot;center&quot;&gt;&lt;em&gt;Shareholders approve all proposed resolutions&lt;/em&gt;&lt;/p&gt;  &lt;p align=&quot;justify&quot;&gt;EINDHOVEN, the Netherlands, May  13, 2026  (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: ONWD – US ADR: ONWRY), the leading neurotechnology company pioneering therapies to restore movement, function, and independence in people with spinal cord injuries (SCI) and other movement disabilities, today announced that all proposed resolutions at its Annual General Meeting of Shareholders (AGM) were duly passed.&lt;/p&gt;  &lt;p align=&quot;justify&quot;&gt;The meeting was held today in Amsterdam, the Netherlands.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/ONWARD+Medical+Announces+Results+of+the+2026+Annual+General+Meeting+of+Shareholders/26484281.html</guid>
   <pubDate>Wed, 13 May 2026 11:57:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.26337272</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ONWD</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ONWD</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ONWRY</category>
   	  </item>
  <item>
   <title>ONWARD Medical Announces Results of the 2026 Annual General Meeting of Shareholders</title>
   <link>http://www.streetinsider.com/Globe+Newswire/ONWARD+Medical+Announces+Results+of+the+2026+Annual+General+Meeting+of+Shareholders/26484281.html</link>
   <description>
&lt;p align=&quot;center&quot;&gt;THIS PRESS RELEASE CONTAINS INSIDE INFORMATION WITHIN THE MEANING OF ARTICLE 7(1) OF THE EUROPEAN MARKET ABUSE REGULATION (596/2014)&lt;/p&gt;  &lt;p align=&quot;center&quot;&gt;&lt;em&gt;Shareholders approve all proposed resolutions&lt;/em&gt;&lt;/p&gt;  &lt;p align=&quot;justify&quot;&gt;EINDHOVEN, the Netherlands, May  13, 2026  (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: ONWD – US ADR: ONWRY), the leading neurotechnology company pioneering therapies to restore movement, function, and independence in people with spinal cord injuries (SCI) and other movement disabilities, today announced that all proposed resolutions at its Annual General Meeting of Shareholders (AGM) were duly passed.&lt;/p&gt;  &lt;p align=&quot;justify&quot;&gt;The meeting was held today in Amsterdam, the Netherlands.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/ONWARD+Medical+Announces+Results+of+the+2026+Annual+General+Meeting+of+Shareholders/26484281.html</guid>
   <pubDate>Wed, 13 May 2026 11:57:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.26337272</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ONWD</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ONWD</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ONWRY</category>
   	  </item>
  <item>
   <title>ONWARD Medical Announces Results of the 2026 Annual General Meeting of Shareholders</title>
   <link>http://www.streetinsider.com/Globe+Newswire/ONWARD+Medical+Announces+Results+of+the+2026+Annual+General+Meeting+of+Shareholders/26484281.html</link>
   <description>
&lt;p align=&quot;center&quot;&gt;THIS PRESS RELEASE CONTAINS INSIDE INFORMATION WITHIN THE MEANING OF ARTICLE 7(1) OF THE EUROPEAN MARKET ABUSE REGULATION (596/2014)&lt;/p&gt;  &lt;p align=&quot;center&quot;&gt;&lt;em&gt;Shareholders approve all proposed resolutions&lt;/em&gt;&lt;/p&gt;  &lt;p align=&quot;justify&quot;&gt;EINDHOVEN, the Netherlands, May  13, 2026  (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: ONWD – US ADR: ONWRY), the leading neurotechnology company pioneering therapies to restore movement, function, and independence in people with spinal cord injuries (SCI) and other movement disabilities, today announced that all proposed resolutions at its Annual General Meeting of Shareholders (AGM) were duly passed.&lt;/p&gt;  &lt;p align=&quot;justify&quot;&gt;The meeting was held today in Amsterdam, the Netherlands.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/ONWARD+Medical+Announces+Results+of+the+2026+Annual+General+Meeting+of+Shareholders/26484281.html</guid>
   <pubDate>Wed, 13 May 2026 11:57:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.26337272</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ONWD</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ONWD</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ONWRY</category>
   	  </item>
  <item>
   <title>ONWARD Medical Publishes Convocation of the 2026 Annual General Meeting of Shareholders and Proposed Resolutions</title>
   <link>http://www.streetinsider.com/Press+Releases/ONWARD+Medical+Publishes+Convocation+of+the+2026+Annual+General+Meeting+of+Shareholders+and+Proposed+Resolutions/26253524.html</link>
   <description>
&lt;p align=&quot;justify&quot;&gt;EINDHOVEN, the Netherlands, April  01, 2026  (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: ONWD – US ADR: ONWRY), the leading neurotechnology company pioneering therapies to restore movement, function, and independence in people with spinal cord injuries (SCI) and other movement disabilities, today convened the 2026 Annual General Meeting of Shareholders (AGM), which will be held in Amsterdam, the Netherlands, on May 13, 2026.&lt;/p&gt;  &lt;p align=&quot;justify&quot;&gt;The resolutions proposed by the Board, to be submitted for adoption at the AGM, are as follows:&lt;/p&gt;  &lt;ol style=&quot;list-style-type:decimal;&quot;&gt;&lt;li style=&quot;margin-top:12pt; margin-bottom:12pt; text-align:justify;&quot;&gt;Discussion of the annual report over the financial year 2025 (&lt;em&gt;discussion item&lt;/em&gt;) &lt;/li&gt;&lt;li style=&quot;margin-top:12pt;</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/ONWARD+Medical+Publishes+Convocation+of+the+2026+Annual+General+Meeting+of+Shareholders+and+Proposed+Resolutions/26253524.html</guid>
   <pubDate>Wed, 01 Apr 2026 02:45:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.50201108</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.03258573</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.26337272</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ONWD</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ONWD</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ONWRY</category>
   	  </item>
  <item>
   <title>ONWARD Medical Publishes Convocation of the 2026 Annual General Meeting of Shareholders and Proposed Resolutions</title>
   <link>http://www.streetinsider.com/Press+Releases/ONWARD+Medical+Publishes+Convocation+of+the+2026+Annual+General+Meeting+of+Shareholders+and+Proposed+Resolutions/26253524.html</link>
   <description>
&lt;p align=&quot;justify&quot;&gt;EINDHOVEN, the Netherlands, April  01, 2026  (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: ONWD – US ADR: ONWRY), the leading neurotechnology company pioneering therapies to restore movement, function, and independence in people with spinal cord injuries (SCI) and other movement disabilities, today convened the 2026 Annual General Meeting of Shareholders (AGM), which will be held in Amsterdam, the Netherlands, on May 13, 2026.&lt;/p&gt;  &lt;p align=&quot;justify&quot;&gt;The resolutions proposed by the Board, to be submitted for adoption at the AGM, are as follows:&lt;/p&gt;  &lt;ol style=&quot;list-style-type:decimal;&quot;&gt;&lt;li style=&quot;margin-top:12pt; margin-bottom:12pt; text-align:justify;&quot;&gt;Discussion of the annual report over the financial year 2025 (&lt;em&gt;discussion item&lt;/em&gt;) &lt;/li&gt;&lt;li style=&quot;margin-top:12pt;</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/ONWARD+Medical+Publishes+Convocation+of+the+2026+Annual+General+Meeting+of+Shareholders+and+Proposed+Resolutions/26253524.html</guid>
   <pubDate>Wed, 01 Apr 2026 02:45:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.50201108</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.03258573</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.26337272</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ONWD</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ONWD</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ONWRY</category>
   	  </item>
  <item>
   <title>ONWARD Medical Publishes Convocation of the 2026 Annual General Meeting of Shareholders and Proposed Resolutions</title>
   <link>http://www.streetinsider.com/Press+Releases/ONWARD+Medical+Publishes+Convocation+of+the+2026+Annual+General+Meeting+of+Shareholders+and+Proposed+Resolutions/26253524.html</link>
   <description>
&lt;p align=&quot;justify&quot;&gt;EINDHOVEN, the Netherlands, April  01, 2026  (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: ONWD – US ADR: ONWRY), the leading neurotechnology company pioneering therapies to restore movement, function, and independence in people with spinal cord injuries (SCI) and other movement disabilities, today convened the 2026 Annual General Meeting of Shareholders (AGM), which will be held in Amsterdam, the Netherlands, on May 13, 2026.&lt;/p&gt;  &lt;p align=&quot;justify&quot;&gt;The resolutions proposed by the Board, to be submitted for adoption at the AGM, are as follows:&lt;/p&gt;  &lt;ol style=&quot;list-style-type:decimal;&quot;&gt;&lt;li style=&quot;margin-top:12pt; margin-bottom:12pt; text-align:justify;&quot;&gt;Discussion of the annual report over the financial year 2025 (&lt;em&gt;discussion item&lt;/em&gt;) &lt;/li&gt;&lt;li style=&quot;margin-top:12pt;</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/ONWARD+Medical+Publishes+Convocation+of+the+2026+Annual+General+Meeting+of+Shareholders+and+Proposed+Resolutions/26253524.html</guid>
   <pubDate>Wed, 01 Apr 2026 02:45:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.50201108</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.03258573</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.26337272</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ONWD</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ONWD</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ONWRY</category>
   	  </item>
  <item>
   <title>ONWARD Medical Publishes Convocation of the 2026 Annual General Meeting of Shareholders and Proposed Resolutions</title>
   <link>http://www.streetinsider.com/Press+Releases/ONWARD+Medical+Publishes+Convocation+of+the+2026+Annual+General+Meeting+of+Shareholders+and+Proposed+Resolutions/26253524.html</link>
   <description>
&lt;p align=&quot;justify&quot;&gt;EINDHOVEN, the Netherlands, April  01, 2026  (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: ONWD – US ADR: ONWRY), the leading neurotechnology company pioneering therapies to restore movement, function, and independence in people with spinal cord injuries (SCI) and other movement disabilities, today convened the 2026 Annual General Meeting of Shareholders (AGM), which will be held in Amsterdam, the Netherlands, on May 13, 2026.&lt;/p&gt;  &lt;p align=&quot;justify&quot;&gt;The resolutions proposed by the Board, to be submitted for adoption at the AGM, are as follows:&lt;/p&gt;  &lt;ol style=&quot;list-style-type:decimal;&quot;&gt;&lt;li style=&quot;margin-top:12pt; margin-bottom:12pt; text-align:justify;&quot;&gt;Discussion of the annual report over the financial year 2025 (&lt;em&gt;discussion item&lt;/em&gt;) &lt;/li&gt;&lt;li style=&quot;margin-top:12pt;</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/ONWARD+Medical+Publishes+Convocation+of+the+2026+Annual+General+Meeting+of+Shareholders+and+Proposed+Resolutions/26253524.html</guid>
   <pubDate>Wed, 01 Apr 2026 02:45:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.50201108</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.03258573</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.26337272</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ONWD</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ONWD</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ONWRY</category>
   	  </item>
  <item>
   <title>ONWARD Medical Publishes Convocation of the 2026 Annual General Meeting of Shareholders and Proposed Resolutions</title>
   <link>http://www.streetinsider.com/Press+Releases/ONWARD+Medical+Publishes+Convocation+of+the+2026+Annual+General+Meeting+of+Shareholders+and+Proposed+Resolutions/26253524.html</link>
   <description>
&lt;p align=&quot;justify&quot;&gt;EINDHOVEN, the Netherlands, April  01, 2026  (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: ONWD – US ADR: ONWRY), the leading neurotechnology company pioneering therapies to restore movement, function, and independence in people with spinal cord injuries (SCI) and other movement disabilities, today convened the 2026 Annual General Meeting of Shareholders (AGM), which will be held in Amsterdam, the Netherlands, on May 13, 2026.&lt;/p&gt;  &lt;p align=&quot;justify&quot;&gt;The resolutions proposed by the Board, to be submitted for adoption at the AGM, are as follows:&lt;/p&gt;  &lt;ol style=&quot;list-style-type:decimal;&quot;&gt;&lt;li style=&quot;margin-top:12pt; margin-bottom:12pt; text-align:justify;&quot;&gt;Discussion of the annual report over the financial year 2025 (&lt;em&gt;discussion item&lt;/em&gt;) &lt;/li&gt;&lt;li style=&quot;margin-top:12pt;</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/ONWARD+Medical+Publishes+Convocation+of+the+2026+Annual+General+Meeting+of+Shareholders+and+Proposed+Resolutions/26253524.html</guid>
   <pubDate>Wed, 01 Apr 2026 02:45:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.50201108</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.03258573</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.26337272</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ONWD</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ONWD</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ONWRY</category>
   	  </item>
  <item>
   <title>ONWARD Medical Publishes Convocation of the 2026 Annual General Meeting of Shareholders and Proposed Resolutions</title>
   <link>http://www.streetinsider.com/Press+Releases/ONWARD+Medical+Publishes+Convocation+of+the+2026+Annual+General+Meeting+of+Shareholders+and+Proposed+Resolutions/26253524.html</link>
   <description>
&lt;p align=&quot;justify&quot;&gt;EINDHOVEN, the Netherlands, April  01, 2026  (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: ONWD – US ADR: ONWRY), the leading neurotechnology company pioneering therapies to restore movement, function, and independence in people with spinal cord injuries (SCI) and other movement disabilities, today convened the 2026 Annual General Meeting of Shareholders (AGM), which will be held in Amsterdam, the Netherlands, on May 13, 2026.&lt;/p&gt;  &lt;p align=&quot;justify&quot;&gt;The resolutions proposed by the Board, to be submitted for adoption at the AGM, are as follows:&lt;/p&gt;  &lt;ol style=&quot;list-style-type:decimal;&quot;&gt;&lt;li style=&quot;margin-top:12pt; margin-bottom:12pt; text-align:justify;&quot;&gt;Discussion of the annual report over the financial year 2025 (&lt;em&gt;discussion item&lt;/em&gt;) &lt;/li&gt;&lt;li style=&quot;margin-top:12pt;</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/ONWARD+Medical+Publishes+Convocation+of+the+2026+Annual+General+Meeting+of+Shareholders+and+Proposed+Resolutions/26253524.html</guid>
   <pubDate>Wed, 01 Apr 2026 02:45:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.50201108</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.03258573</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.26337272</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ONWD</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ONWD</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ONWRY</category>
   	  </item>
  <item>
   <title>ONWARD Medical Publishes Convocation of the 2026 Annual General Meeting of Shareholders and Proposed Resolutions</title>
   <link>http://www.streetinsider.com/Globe+Newswire/ONWARD+Medical+Publishes+Convocation+of+the+2026+Annual+General+Meeting+of+Shareholders+and+Proposed+Resolutions/26253524.html</link>
   <description>
&lt;p align=&quot;justify&quot;&gt;EINDHOVEN, the Netherlands, April  01, 2026  (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: ONWD – US ADR: ONWRY), the leading neurotechnology company pioneering therapies to restore movement, function, and independence in people with spinal cord injuries (SCI) and other movement disabilities, today convened the 2026 Annual General Meeting of Shareholders (AGM), which will be held in Amsterdam, the Netherlands, on May 13, 2026.&lt;/p&gt;  &lt;p align=&quot;justify&quot;&gt;The resolutions proposed by the Board, to be submitted for adoption at the AGM, are as follows:&lt;/p&gt;  &lt;ol style=&quot;list-style-type:decimal;&quot;&gt;&lt;li style=&quot;margin-top:12pt; margin-bottom:12pt; text-align:justify;&quot;&gt;Discussion of the annual report over the financial year 2025 (&lt;em&gt;discussion item&lt;/em&gt;) &lt;/li&gt;&lt;li style=&quot;margin-top:12pt;</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/ONWARD+Medical+Publishes+Convocation+of+the+2026+Annual+General+Meeting+of+Shareholders+and+Proposed+Resolutions/26253524.html</guid>
   <pubDate>Wed, 01 Apr 2026 02:45:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.50201108</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.03258573</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.26337272</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ONWD</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ONWD</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ONWRY</category>
   	  </item>
  <item>
   <title>ONWARD Medical Publishes Convocation of the 2026 Annual General Meeting of Shareholders and Proposed Resolutions</title>
   <link>http://www.streetinsider.com/Globe+Newswire/ONWARD+Medical+Publishes+Convocation+of+the+2026+Annual+General+Meeting+of+Shareholders+and+Proposed+Resolutions/26253524.html</link>
   <description>
&lt;p align=&quot;justify&quot;&gt;EINDHOVEN, the Netherlands, April  01, 2026  (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: ONWD – US ADR: ONWRY), the leading neurotechnology company pioneering therapies to restore movement, function, and independence in people with spinal cord injuries (SCI) and other movement disabilities, today convened the 2026 Annual General Meeting of Shareholders (AGM), which will be held in Amsterdam, the Netherlands, on May 13, 2026.&lt;/p&gt;  &lt;p align=&quot;justify&quot;&gt;The resolutions proposed by the Board, to be submitted for adoption at the AGM, are as follows:&lt;/p&gt;  &lt;ol style=&quot;list-style-type:decimal;&quot;&gt;&lt;li style=&quot;margin-top:12pt; margin-bottom:12pt; text-align:justify;&quot;&gt;Discussion of the annual report over the financial year 2025 (&lt;em&gt;discussion item&lt;/em&gt;) &lt;/li&gt;&lt;li style=&quot;margin-top:12pt;</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/ONWARD+Medical+Publishes+Convocation+of+the+2026+Annual+General+Meeting+of+Shareholders+and+Proposed+Resolutions/26253524.html</guid>
   <pubDate>Wed, 01 Apr 2026 02:45:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.50201108</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.03258573</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.26337272</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ONWD</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ONWD</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ONWRY</category>
   	  </item>
  <item>
   <title>ONWARD Medical Publishes Convocation of the 2026 Annual General Meeting of Shareholders and Proposed Resolutions</title>
   <link>http://www.streetinsider.com/Globe+Newswire/ONWARD+Medical+Publishes+Convocation+of+the+2026+Annual+General+Meeting+of+Shareholders+and+Proposed+Resolutions/26253524.html</link>
   <description>
&lt;p align=&quot;justify&quot;&gt;EINDHOVEN, the Netherlands, April  01, 2026  (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: ONWD – US ADR: ONWRY), the leading neurotechnology company pioneering therapies to restore movement, function, and independence in people with spinal cord injuries (SCI) and other movement disabilities, today convened the 2026 Annual General Meeting of Shareholders (AGM), which will be held in Amsterdam, the Netherlands, on May 13, 2026.&lt;/p&gt;  &lt;p align=&quot;justify&quot;&gt;The resolutions proposed by the Board, to be submitted for adoption at the AGM, are as follows:&lt;/p&gt;  &lt;ol style=&quot;list-style-type:decimal;&quot;&gt;&lt;li style=&quot;margin-top:12pt; margin-bottom:12pt; text-align:justify;&quot;&gt;Discussion of the annual report over the financial year 2025 (&lt;em&gt;discussion item&lt;/em&gt;) &lt;/li&gt;&lt;li style=&quot;margin-top:12pt;</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/ONWARD+Medical+Publishes+Convocation+of+the+2026+Annual+General+Meeting+of+Shareholders+and+Proposed+Resolutions/26253524.html</guid>
   <pubDate>Wed, 01 Apr 2026 02:45:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.50201108</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.03258573</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.26337272</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ONWD</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ONWD</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ONWRY</category>
   	  </item>
  <item>
   <title>ONWARD Medical Publishes Convocation of the 2026 Annual General Meeting of Shareholders and Proposed Resolutions</title>
   <link>http://www.streetinsider.com/Globe+Newswire/ONWARD+Medical+Publishes+Convocation+of+the+2026+Annual+General+Meeting+of+Shareholders+and+Proposed+Resolutions/26253524.html</link>
   <description>
&lt;p align=&quot;justify&quot;&gt;EINDHOVEN, the Netherlands, April  01, 2026  (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: ONWD – US ADR: ONWRY), the leading neurotechnology company pioneering therapies to restore movement, function, and independence in people with spinal cord injuries (SCI) and other movement disabilities, today convened the 2026 Annual General Meeting of Shareholders (AGM), which will be held in Amsterdam, the Netherlands, on May 13, 2026.&lt;/p&gt;  &lt;p align=&quot;justify&quot;&gt;The resolutions proposed by the Board, to be submitted for adoption at the AGM, are as follows:&lt;/p&gt;  &lt;ol style=&quot;list-style-type:decimal;&quot;&gt;&lt;li style=&quot;margin-top:12pt; margin-bottom:12pt; text-align:justify;&quot;&gt;Discussion of the annual report over the financial year 2025 (&lt;em&gt;discussion item&lt;/em&gt;) &lt;/li&gt;&lt;li style=&quot;margin-top:12pt;</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/ONWARD+Medical+Publishes+Convocation+of+the+2026+Annual+General+Meeting+of+Shareholders+and+Proposed+Resolutions/26253524.html</guid>
   <pubDate>Wed, 01 Apr 2026 02:45:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.50201108</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.03258573</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.26337272</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ONWD</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ONWD</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ONWRY</category>
   	  </item>
  <item>
   <title>ONWARD Medical Publishes Convocation of the 2026 Annual General Meeting of Shareholders and Proposed Resolutions</title>
   <link>http://www.streetinsider.com/Globe+Newswire/ONWARD+Medical+Publishes+Convocation+of+the+2026+Annual+General+Meeting+of+Shareholders+and+Proposed+Resolutions/26253524.html</link>
   <description>
&lt;p align=&quot;justify&quot;&gt;EINDHOVEN, the Netherlands, April  01, 2026  (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: ONWD – US ADR: ONWRY), the leading neurotechnology company pioneering therapies to restore movement, function, and independence in people with spinal cord injuries (SCI) and other movement disabilities, today convened the 2026 Annual General Meeting of Shareholders (AGM), which will be held in Amsterdam, the Netherlands, on May 13, 2026.&lt;/p&gt;  &lt;p align=&quot;justify&quot;&gt;The resolutions proposed by the Board, to be submitted for adoption at the AGM, are as follows:&lt;/p&gt;  &lt;ol style=&quot;list-style-type:decimal;&quot;&gt;&lt;li style=&quot;margin-top:12pt; margin-bottom:12pt; text-align:justify;&quot;&gt;Discussion of the annual report over the financial year 2025 (&lt;em&gt;discussion item&lt;/em&gt;) &lt;/li&gt;&lt;li style=&quot;margin-top:12pt;</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/ONWARD+Medical+Publishes+Convocation+of+the+2026+Annual+General+Meeting+of+Shareholders+and+Proposed+Resolutions/26253524.html</guid>
   <pubDate>Wed, 01 Apr 2026 02:45:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.50201108</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.03258573</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.26337272</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ONWD</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ONWD</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ONWRY</category>
   	  </item>
  <item>
   <title>ONWARD Medical Publishes Convocation of the 2026 Annual General Meeting of Shareholders and Proposed Resolutions</title>
   <link>http://www.streetinsider.com/Globe+Newswire/ONWARD+Medical+Publishes+Convocation+of+the+2026+Annual+General+Meeting+of+Shareholders+and+Proposed+Resolutions/26253524.html</link>
   <description>
&lt;p align=&quot;justify&quot;&gt;EINDHOVEN, the Netherlands, April  01, 2026  (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: ONWD – US ADR: ONWRY), the leading neurotechnology company pioneering therapies to restore movement, function, and independence in people with spinal cord injuries (SCI) and other movement disabilities, today convened the 2026 Annual General Meeting of Shareholders (AGM), which will be held in Amsterdam, the Netherlands, on May 13, 2026.&lt;/p&gt;  &lt;p align=&quot;justify&quot;&gt;The resolutions proposed by the Board, to be submitted for adoption at the AGM, are as follows:&lt;/p&gt;  &lt;ol style=&quot;list-style-type:decimal;&quot;&gt;&lt;li style=&quot;margin-top:12pt; margin-bottom:12pt; text-align:justify;&quot;&gt;Discussion of the annual report over the financial year 2025 (&lt;em&gt;discussion item&lt;/em&gt;) &lt;/li&gt;&lt;li style=&quot;margin-top:12pt;</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/ONWARD+Medical+Publishes+Convocation+of+the+2026+Annual+General+Meeting+of+Shareholders+and+Proposed+Resolutions/26253524.html</guid>
   <pubDate>Wed, 01 Apr 2026 02:45:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.50201108</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.03258573</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.26337272</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ONWD</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ONWD</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ONWRY</category>
   	  </item>
  <item>
   <title>ONWARD Medical Announces First Participant Enrolled in Global Pivotal Study Evaluating ARC-IM System to Address Blood Pressure Instability After Spinal Cord Injury</title>
   <link>http://www.streetinsider.com/Press+Releases/ONWARD+Medical+Announces+First+Participant+Enrolled+in+Global+Pivotal+Study+Evaluating+ARC-IM+System+to+Address+Blood+Pressure+Instability+After+Spinal+Cord+Injury/25941611.html</link>
   <description>
&lt;ul&gt;&lt;li style=&quot;text-align:justify;&quot;&gt;&lt;em&gt;Empower BP is a landmark global pivotal study evaluating the safety and effectiveness&lt;/em&gt; &lt;em&gt;of the implantable ARC-IM&lt;/em&gt;&lt;em&gt;®&lt;/em&gt;&lt;em&gt; System&lt;/em&gt; &lt;em&gt;to address blood pressure instability after spinal cord injury (SCI)&lt;/em&gt;&lt;/li&gt;&lt;li style=&quot;text-align:justify;&quot;&gt;&lt;em&gt;Blood pressure instability is a key unmet need after SCI, with a significant impact on cardiovascular health and quality of life&lt;/em&gt;&lt;/li&gt;&lt;li style=&quot;text-align:justify;&quot;&gt;&lt;em&gt;The first participant was enrolled at Craig Hospital in Denver, Colorado, USA&lt;br/&gt;&lt;/em&gt;&lt;br/&gt;&lt;/li&gt;&lt;/ul&gt;  &lt;p align=&quot;justify&quot;&gt;EINDHOVEN, the Netherlands, Feb.  04, 2026  (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: ONWD and US OTCQX: ONWRY), the neurotechnology company pioneering spinal cord stimulation therapies to restore movement, function, and independence, today announces</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/ONWARD+Medical+Announces+First+Participant+Enrolled+in+Global+Pivotal+Study+Evaluating+ARC-IM+System+to+Address+Blood+Pressure+Instability+After+Spinal+Cord+Injury/25941611.html</guid>
   <pubDate>Wed, 04 Feb 2026 01:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.02627437</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50204662</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00048918</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00165137</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.26337272</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ONWD</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ONWD</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ONWRY</category>
   	  </item>
  <item>
   <title>ONWARD Medical Announces First Participant Enrolled in Global Pivotal Study Evaluating ARC-IM System to Address Blood Pressure Instability After Spinal Cord Injury</title>
   <link>http://www.streetinsider.com/Press+Releases/ONWARD+Medical+Announces+First+Participant+Enrolled+in+Global+Pivotal+Study+Evaluating+ARC-IM+System+to+Address+Blood+Pressure+Instability+After+Spinal+Cord+Injury/25941611.html</link>
   <description>
&lt;ul&gt;&lt;li style=&quot;text-align:justify;&quot;&gt;&lt;em&gt;Empower BP is a landmark global pivotal study evaluating the safety and effectiveness&lt;/em&gt; &lt;em&gt;of the implantable ARC-IM&lt;/em&gt;&lt;em&gt;®&lt;/em&gt;&lt;em&gt; System&lt;/em&gt; &lt;em&gt;to address blood pressure instability after spinal cord injury (SCI)&lt;/em&gt;&lt;/li&gt;&lt;li style=&quot;text-align:justify;&quot;&gt;&lt;em&gt;Blood pressure instability is a key unmet need after SCI, with a significant impact on cardiovascular health and quality of life&lt;/em&gt;&lt;/li&gt;&lt;li style=&quot;text-align:justify;&quot;&gt;&lt;em&gt;The first participant was enrolled at Craig Hospital in Denver, Colorado, USA&lt;br/&gt;&lt;/em&gt;&lt;br/&gt;&lt;/li&gt;&lt;/ul&gt;  &lt;p align=&quot;justify&quot;&gt;EINDHOVEN, the Netherlands, Feb.  04, 2026  (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: ONWD and US OTCQX: ONWRY), the neurotechnology company pioneering spinal cord stimulation therapies to restore movement, function, and independence, today announces</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/ONWARD+Medical+Announces+First+Participant+Enrolled+in+Global+Pivotal+Study+Evaluating+ARC-IM+System+to+Address+Blood+Pressure+Instability+After+Spinal+Cord+Injury/25941611.html</guid>
   <pubDate>Wed, 04 Feb 2026 01:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.02627437</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50204662</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00048918</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00165137</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.26337272</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ONWD</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ONWD</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ONWRY</category>
   	  </item>
  <item>
   <title>ONWARD Medical Announces First Participant Enrolled in Global Pivotal Study Evaluating ARC-IM System to Address Blood Pressure Instability After Spinal Cord Injury</title>
   <link>http://www.streetinsider.com/Press+Releases/ONWARD+Medical+Announces+First+Participant+Enrolled+in+Global+Pivotal+Study+Evaluating+ARC-IM+System+to+Address+Blood+Pressure+Instability+After+Spinal+Cord+Injury/25941611.html</link>
   <description>
&lt;ul&gt;&lt;li style=&quot;text-align:justify;&quot;&gt;&lt;em&gt;Empower BP is a landmark global pivotal study evaluating the safety and effectiveness&lt;/em&gt; &lt;em&gt;of the implantable ARC-IM&lt;/em&gt;&lt;em&gt;®&lt;/em&gt;&lt;em&gt; System&lt;/em&gt; &lt;em&gt;to address blood pressure instability after spinal cord injury (SCI)&lt;/em&gt;&lt;/li&gt;&lt;li style=&quot;text-align:justify;&quot;&gt;&lt;em&gt;Blood pressure instability is a key unmet need after SCI, with a significant impact on cardiovascular health and quality of life&lt;/em&gt;&lt;/li&gt;&lt;li style=&quot;text-align:justify;&quot;&gt;&lt;em&gt;The first participant was enrolled at Craig Hospital in Denver, Colorado, USA&lt;br/&gt;&lt;/em&gt;&lt;br/&gt;&lt;/li&gt;&lt;/ul&gt;  &lt;p align=&quot;justify&quot;&gt;EINDHOVEN, the Netherlands, Feb.  04, 2026  (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: ONWD and US OTCQX: ONWRY), the neurotechnology company pioneering spinal cord stimulation therapies to restore movement, function, and independence, today announces</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/ONWARD+Medical+Announces+First+Participant+Enrolled+in+Global+Pivotal+Study+Evaluating+ARC-IM+System+to+Address+Blood+Pressure+Instability+After+Spinal+Cord+Injury/25941611.html</guid>
   <pubDate>Wed, 04 Feb 2026 01:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.02627437</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50204662</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00048918</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00165137</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.26337272</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ONWD</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ONWD</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ONWRY</category>
   	  </item>
  <item>
   <title>ONWARD Medical Announces First Participant Enrolled in Global Pivotal Study Evaluating ARC-IM System to Address Blood Pressure Instability After Spinal Cord Injury</title>
   <link>http://www.streetinsider.com/Press+Releases/ONWARD+Medical+Announces+First+Participant+Enrolled+in+Global+Pivotal+Study+Evaluating+ARC-IM+System+to+Address+Blood+Pressure+Instability+After+Spinal+Cord+Injury/25941611.html</link>
   <description>
&lt;ul&gt;&lt;li style=&quot;text-align:justify;&quot;&gt;&lt;em&gt;Empower BP is a landmark global pivotal study evaluating the safety and effectiveness&lt;/em&gt; &lt;em&gt;of the implantable ARC-IM&lt;/em&gt;&lt;em&gt;®&lt;/em&gt;&lt;em&gt; System&lt;/em&gt; &lt;em&gt;to address blood pressure instability after spinal cord injury (SCI)&lt;/em&gt;&lt;/li&gt;&lt;li style=&quot;text-align:justify;&quot;&gt;&lt;em&gt;Blood pressure instability is a key unmet need after SCI, with a significant impact on cardiovascular health and quality of life&lt;/em&gt;&lt;/li&gt;&lt;li style=&quot;text-align:justify;&quot;&gt;&lt;em&gt;The first participant was enrolled at Craig Hospital in Denver, Colorado, USA&lt;br/&gt;&lt;/em&gt;&lt;br/&gt;&lt;/li&gt;&lt;/ul&gt;  &lt;p align=&quot;justify&quot;&gt;EINDHOVEN, the Netherlands, Feb.  04, 2026  (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: ONWD and US OTCQX: ONWRY), the neurotechnology company pioneering spinal cord stimulation therapies to restore movement, function, and independence, today announces</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/ONWARD+Medical+Announces+First+Participant+Enrolled+in+Global+Pivotal+Study+Evaluating+ARC-IM+System+to+Address+Blood+Pressure+Instability+After+Spinal+Cord+Injury/25941611.html</guid>
   <pubDate>Wed, 04 Feb 2026 01:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.02627437</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50204662</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00048918</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00165137</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.26337272</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ONWD</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ONWD</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ONWRY</category>
   	  </item>
  <item>
   <title>ONWARD Medical Announces First Participant Enrolled in Global Pivotal Study Evaluating ARC-IM System to Address Blood Pressure Instability After Spinal Cord Injury</title>
   <link>http://www.streetinsider.com/Press+Releases/ONWARD+Medical+Announces+First+Participant+Enrolled+in+Global+Pivotal+Study+Evaluating+ARC-IM+System+to+Address+Blood+Pressure+Instability+After+Spinal+Cord+Injury/25941611.html</link>
   <description>
&lt;ul&gt;&lt;li style=&quot;text-align:justify;&quot;&gt;&lt;em&gt;Empower BP is a landmark global pivotal study evaluating the safety and effectiveness&lt;/em&gt; &lt;em&gt;of the implantable ARC-IM&lt;/em&gt;&lt;em&gt;®&lt;/em&gt;&lt;em&gt; System&lt;/em&gt; &lt;em&gt;to address blood pressure instability after spinal cord injury (SCI)&lt;/em&gt;&lt;/li&gt;&lt;li style=&quot;text-align:justify;&quot;&gt;&lt;em&gt;Blood pressure instability is a key unmet need after SCI, with a significant impact on cardiovascular health and quality of life&lt;/em&gt;&lt;/li&gt;&lt;li style=&quot;text-align:justify;&quot;&gt;&lt;em&gt;The first participant was enrolled at Craig Hospital in Denver, Colorado, USA&lt;br/&gt;&lt;/em&gt;&lt;br/&gt;&lt;/li&gt;&lt;/ul&gt;  &lt;p align=&quot;justify&quot;&gt;EINDHOVEN, the Netherlands, Feb.  04, 2026  (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: ONWD and US OTCQX: ONWRY), the neurotechnology company pioneering spinal cord stimulation therapies to restore movement, function, and independence, today announces</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/ONWARD+Medical+Announces+First+Participant+Enrolled+in+Global+Pivotal+Study+Evaluating+ARC-IM+System+to+Address+Blood+Pressure+Instability+After+Spinal+Cord+Injury/25941611.html</guid>
   <pubDate>Wed, 04 Feb 2026 01:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.02627437</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50204662</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00048918</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00165137</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.26337272</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ONWD</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ONWD</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ONWRY</category>
   	  </item>
 </channel>
</rss>
